Structural diversification of vitamin D using microbial biotransformations.

Area of Science:

• Biochemistry
• Biotechnology
• Medical Science

Background:

• Vitamin D deficiency is linked to numerous human diseases, necessitating optimized synthesis and delivery.
• Current challenges include improving vitamin D absorption, stability, and minimizing side effects like hypercalcemia.
• Biotechnological modifications and microbial bioconversions are key areas of research for enhanced vitamin D production.

Purpose of the Study:

• To detail the physiological, medical, biochemical, and epidemiological aspects of vitamin D supplementation.
• To explore the potential of biotechnological techniques and microbial bioconversions for novel vitamin D derivative development.
• To outline steps for enhanced and simplified industrial production of vitamin D and its analogs.

Main Methods:

• Review of physiological, medical, biochemical, and epidemiological data on vitamin D.
• Exploration of biotechnological strategies for modifying vitamin D.
• Investigation of microbial bioconversions for vitamin D analog synthesis.

Main Results:

• Novel modified vitamin D derivatives show promise for improved therapeutic applications.
• Microbial bioconversions, particularly by Actinomycetes, can perform key hydroxylation steps (1α- or 25-hydroxylation) on vitamin D precursors.
• Engineered enzymes and biosynthetic pathways are crucial for developing efficient production methods.

Conclusions:

• Biotechnological approaches and microbial bioconversions are vital for creating safer, more effective vitamin D analogs.
• Optimized industrial production of vitamin D derivatives can address deficiencies and specific health concerns.
• Further research into enzyme engineering and microbial systems will advance vitamin D therapeutics.